Zappy Health's official pages show conflicting pricing structures—one page advertises introductory semaglutide and tirzepatide rates, while another shows different introductory rates rising to higher ongoing costs. We calculate 12-month costs under both scenarios and compare like-for-like plans.

Most GLP-1 programs advertise a low first-month rate but charge substantially more on refill. We normalize 20+ telehealth programs to show what you actually pay over 12 months.

OrderlyMeds offers a prepaid starter period that reduces early costs, while Zappy Health's website shows conflicting prices that warrant checkout confirmation. Here's the verified rate structure for each provider, normalized over 12 months, and where PlexusDx fits.

MEDVi publishes a first-month price and a refill price for compounded semaglutide; AltRx publishes starting-at prices for semaglutide and tirzepatide without saying whether they are first-month or recurring. This post compares what each provider actually verifies as of September 22, 2026, what remains unknown, and how the cancellation terms differ.

MEDVi advertises one price for a new patient's first month and a different, higher price for refills. This guide explains why the two figures are separate fields, which products publish each figure, how to total a multi-cycle course honestly, and which questions to ask before enrolling.